Ildong Pharmaceutical Reports Q2 Sales of 162 Billion KRW, Up 14.6% Year-on-Year
[Asia Economy Reporter Lee Gwan-joo] Ildong Pharmaceutical announced on the 27th that its sales in the second quarter of this year reached 162 billion KRW, a 14.6% increase compared to the same period last year.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Introduces New "Special Performance Bonus" for Semiconductors, Paid Entirely in Company Shares
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- Trump: "Talks with Iran in Final Stages"... Iran Demands Release of Frozen Assets, End to Maritime Blockade
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
During the same period, operating loss increased by 153.1% to 22 billion KRW, and net profit for the period rose by 344% to 50.5 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
